Cytolytic Nanoparticles Attenuate HIV-1 Infectivity
- 1 January 2013
- journal article
- research article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 18 (1), 95-103
- https://doi.org/10.3851/imp2346
Abstract
Background: We investigated whether cytolytic melittin peptides could inhibit HIV-1 infectivity when carried in a nanoparticle construct that might be used as a topical vaginal virucide. Free melittin and melittin-loaded nanoparticles were prepared and compared for cytotoxicity and their ability to inhibit infectivity by CXCR4 and CCR5 tropic HIV-1 strains. Methods: TZM-bl reporter cells expressing luciferase under the control of the HIV-1 promoter were incubated with HIV-1 NLHX (CXCR4) or HIV-1 NLYU2 (CCR5) viral strains and different doses of soluble CD4 (positive control) or free melittin to determine infectivity and viability. Melittin-loaded nanoparticles were formulated and different doses tested against VK2 vaginal epithelial cells to determine cell viability. Based on VK2 viability, melittin nanoparticles were tested for prevention of CXCR4 and CCR5 tropic HIV-1 infectivity and viability of TZM-bl reporter cells. Low-speed centrifugation was used to compare the ability of blank non-melittin nanoparticles and melittin nanoparticles to capture CCR5 tropic HIV-1. Results: As expected, the soluble CD4 positive control inhibited CXCR4 (50% inhibitory concentration [IC50] 3.7 μg/ml) and CCR5 (IC50 0.03 μg/ml) tropic HIV-1 infectivity. Free melittin doses 50 2.4 μM and IC90 6.9 μM) and CCR5 (IC50 3.6 μM and IC90 11.4 μM) strain infectivity of TZM-bl reporter cells. Furthermore, melittin nanoparticles captured more HIV-1 than blank nanoparticles. Conclusions: These data illustrate the first proof-of- concept for therapeutic and safe nanoparticle-mediated inhibition of HIV-1 infectivity. Future investigations appear warranted to explore the antiviral prophylactic potential of melittin nanoparticles to capture, disrupt and prevent initial infection with HIV-1 or potentially other enveloped viruses.Keywords
This publication has 22 references indexed in Scilit:
- Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?Clinical Infectious Diseases, 2011
- Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion StepPLoS Pathogens, 2010
- In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 MicrobicidePLOS ONE, 2010
- Adaptive Mutations in a Human Immunodeficiency Virus Type 1 Envelope Protein with a Truncated V3 Loop Restore Function by Improving Interactions with CD4Journal of Virology, 2009
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growthJCI Insight, 2009
- Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cellsToxicon, 2008
- Synthesis and Characterization of Stable Fluorocarbon Nanostructures as Drug Delivery Vehicles for Cytolytic PeptidesNano Letters, 2008
- Neutralization of Human Immunodeficiency Virus Type 1 by sCD4-17b, a Single-Chain Chimeric Protein, Based on Sequential Interaction of gp120 with CD4 and CoreceptorJournal of Virology, 2003
- p24 Antigen Capture Assay for Quantification of Human Immunodeficiency Virus Using Readily Available Inexpensive ReagentsMethods, 1997
- Particle Size Distribution of Concentrated Perfluorocarbon Emulsions by Sedimentation Field Flow FractionationBiomaterials, Artificial Cells and Immobilization Biotechnology, 1992